Journal of Neuro-Oncology

, Volume 18, Issue 3, pp 207–216

Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas

  • Richard S. Morrison
  • Fumio Yamaguchi
  • Hideyuki Saya
  • Janet M. Bruner
  • Alan M. Yahanda
  • Lawrence A. Donehower
  • Mitchel Berger
Article

Summary

Malignant astrocytomas are highly invasive, vascular neoplasms that comprise the majority of nervous system tumors in humans. A strong association has previously been made between malignancy in human astrocytic tumors and increased expression of certain fibroblast growth factor (FGF) family members, including basic and acidic FGF. The influence of endogenous basic FGF on glioblastoma cell growthin vitro was evaluated using basic FGF-specific antisense oligonucleotides. These studies indicated that human glioblastoma cell growthin vitro, can be inhibited by suppressing basic FGF expression. Human astrocytomas also exhibited changes in FGF receptor (FGFR) expression during the course of their progression from a benign to a malignant phenotype. FGFR2 (bek) expression was abundant in normal white matter and in all low grade astrocytomas, but was not observed in glioblastomas. Conversely, FGFR1 (flg) expression was absent or barely detectable in normal white matter, but was significantly elevated in glioblastomas. Glioblastomas also expressed an alternatively spliced form of FGFR1 containing two immunoglobulin-like disulfide loops (FGFR1β), whereas normal human adult and fetal brain expressed a form of the receptor containing three immunoglobulin-like disulfide loops (FGFR1α). Intermediate grades of astrocytic tumors exhibited a gradual loss of FGFR2 and a shift in expression from FGFR1α to FGFR1β as they progressed from a benigh to a malignant phenotype. The underlying cytogenetic changes that contribute to these alterations are not entirely understood, but abnormalities in the p53 tumor suppressor gene may influence expression of bFGF as well as the FGFR. These results suggest that alterations in FGFR signal transduction pathways may play a critical role in the malignant progression of astrocytic tumors.

Key words

brain tumor astrocytoma glioma central nervous system angiogenesis malignant progression 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Davidson JM, Klagsbrun M, Hill KE, Buckley A, Sullivan R, Brewer PS, Woodward SC: Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor. J Cell Biol 100: 1219–1227, 1975Google Scholar
  2. 2.
    Folkman J, Klagsbrun M: Angiogenic factors. Science 235: 442–447, 1987Google Scholar
  3. 3.
    Baird A, Esch F, Mormede P, Ueno N, Ling N, Bohlen P, Ying SY, Wehrenberg WB, Guillemin R: Molecular characterization of fibroblast growth factor: Distribution and biological activities in various tissues. Recent Prog Horm Res 42: 143–205, 1986Google Scholar
  4. 4.
    Rifkin DB, Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109: 1–6, 1989Google Scholar
  5. 5.
    Slack JMW, Isaccs HV: Presence of basic fibroblast growth factor in the early Xenopus embryo. Development 105: 147–153, 1989Google Scholar
  6. 6.
    Joseph-Silverstein J, Consigli SA, Lyser KM, Ver Fault C: Basic fibroblast growth factor in the chick embryo: immunolocalization to striated muscle cells and their precursors. J Cell Biol 108: 2459–2466, 1989Google Scholar
  7. 7.
    Sasada R, Kurokawa T, Iwane M, Igarashi K: Transformation of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA. Mol Cell Biol 8(2): 588–594, 1988Google Scholar
  8. 8.
    Neufeld G, Mitchell R, Ponte P, Gospodarowicz D: Expression of human basic fibroblast growth factor cDNA in baby hamster kidney-derived cells results in autonomous cell growth. J Cell Biol 106: 1385–1394, 1988Google Scholar
  9. 9.
    Dotto GP, Moellmann G, Ghosh S, Edwards M, Halaban R: Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J Cell Biol 109: 3115–3128, 1989Google Scholar
  10. 10.
    Delli-Bovi PD, Curatola AM, Kern FG, Greco A, Ittmann M, Basilico C: An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50: 729–737, 1987Google Scholar
  11. 11.
    Taira M, Yoshida T, Miyagawa K, Sakamoto H, Terada M, Sugimura T: cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci USA 84: 2980–2984, 1987Google Scholar
  12. 12.
    Smith R, Peters G, Dickson C: Multiple RNAs expressed from the int-2 gene in mouse embryonal carcinoma cell lines encode a protein with homology to fibroblast growth factors. EMBO J 7(4): 1013–1022, 1988Google Scholar
  13. 13.
    Zhan X, Bates B, Hu X, Goldfarb M: The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol Cell Biol 8: 3487–3495, 1988Google Scholar
  14. 14.
    Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245: 752–755, 1989Google Scholar
  15. 15.
    Marics I, Adelaide J, Raybaud F, Mattei MG, Coulier F, Planche J, de Lapeyriere O, Birnbaum D: Characterization of the HST-related FGF6 gene, a new member of the fibroblast growth factor gene family. Oncogene 4: 335–340, 1989Google Scholar
  16. 16.
    Houssaint E, Blanquet PR, Champion-Arnaud P, Gesnel MC, Torriglia A, Courtois Y, Breathnach R: Related fibroblast growth factor receptor genes exist in the human genome. Proc Natl Acad Sci USA 87: 8180–8184, 1990Google Scholar
  17. 17.
    Johnson DE, Lu J, Chen H, Werner S, Williams LT: The human fibroblast growth factor receptor genes: A common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 11: 4627–4634, 1991Google Scholar
  18. 18.
    Keegan K, Johnson DE, Williams LT, Hayman MJ: Isolation of additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci USA 88: 1095–1099, 1991Google Scholar
  19. 19.
    Partanen J, Makela TP, Erola E, Kohonen J, Hirovenen H, Claesson-Welsh L, Alitalo K: FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J 10: 1347–1354, 1991Google Scholar
  20. 20.
    Ruta M, Burgess W, Givol D, Epstein J, Neiger N, Kaplow J, Crumley G, Dionne C, Jaye M, Schlessinger J: Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc Natl Acad Sci USA 86: 8722–8726, 1989Google Scholar
  21. 21.
    Kan M, DiSorbo D, Hou J, Hoshi H, Mansson PE, McKeehan WL: High and low affinity binding of heparin-binding growth factor to a 130-kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma. Cell J Biol Chem 263: 11306–11313, 1988Google Scholar
  22. 22.
    Moscatelli D: High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol 131: 123–130, 1987Google Scholar
  23. 23.
    Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M: Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matarix. Proc Natl Acad Sci USA 84: 2292–2296, 1987Google Scholar
  24. 24.
    Kan M, Shi E: Fibronectin, not laminin, mediates heparin-dependent heparin-binding growth factor type I binding to substrata and stimulation of endothelial cell growth. In Vitro Cell Dev Biol 26: 1151–1156, 1990Google Scholar
  25. 25.
    Yayon A, Klagsburn M, Esko JD, Leder P, Ornitz DM: Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor to its high-affinity receptor. Cell 64: 841–848, 1991Google Scholar
  26. 26.
    Rapraeger AC, Krufka A, Olwin BB: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252: 1705–1708, 1991Google Scholar
  27. 27.
    Dionne CA, Crumley G, Bellor T, Kaplow JM, Searfross G, Ruta M, Burgess WH, Jaye M, Schlessinger J: Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 9: 2685–2692, 1990Google Scholar
  28. 28.
    Johnson DE, Lee PL, Lu J, Williams LT: Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol Cell Biol 10: 4728–4736, 1990Google Scholar
  29. 29.
    Reid HH, Wilks AF, Bernard O: Two forms of basic fibroblast growth factor receptor-like mRNA are expressed in the developing mouse brain. Proc Natl Acad Sci USA 87: 1596–1600, 1990Google Scholar
  30. 30.
    Hou J, Kan M, McKeehan K, McBride G, Adams P, McKeehan WL: Fibroblast growth factors from liver vary in three structural domains. Science 251: 665–668, 1991Google Scholar
  31. 31.
    Werner S, Duan D-SR, de Vries C, Peters KG, Johnson DE, Williams LT: Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 12: 82–88, 1992Google Scholar
  32. 32.
    Shi E, Kan M, Xu J, Wang F, Hou J, McKeehan WL: Control of FGF receptor kinase signal transduction by heterodimerization of combinatorial splice variants. Mol Cell Biol (in press)Google Scholar
  33. 33.
    Eisemann A, Ahn JA, Graziani G, Tronick SR, Ron D: Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene 6: 1195–1202, 1991Google Scholar
  34. 34.
    Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86: 802–806, 1989Google Scholar
  35. 35.
    Pettmann B, Labourdette G, Weibel M, Sensenbrenner M: The brain fibroblast growth factor (FGF) is localized in neurons. Neuroscience Letters 68: 175–180, 1986Google Scholar
  36. 36.
    Janet T, Grothe C, Pettmann B, Unsicker K, Sensenbrenner M: Immunocytochemical demonstration of fibroblast growth factor in cultured chick and rat neurons. J Neurosci Res 19: 195–201, 1988Google Scholar
  37. 37.
    Woodward WR, Nishi R, Meshul CK, Williams TE, Coulombe M, Eckenstein FP: Nuclear and cytoplasmic localization of basic fibroblast growth factor in astrocytes and CA2 hippocampal neurons. J Neurosci 12(1): 142–152, 1992Google Scholar
  38. 38.
    Gomez-Pinilla F, Won-Kyun Lee J, Cotman CW: Basic FGF in adult rat brain: Cellular distribution and response to entorhinal lesion and fimbriafornix transection. J Neurosci 12 (1): 345–355, 1992Google Scholar
  39. 39.
    Araujo DM, Cotman CW: Basic FGF in astroglial, microglial and neuronal cultures: Characterization of binding sites and modulation of release by lymphokines and trophic factors. J Neurosci 12(5): 1668–1678, 1992Google Scholar
  40. 40.
    Yokoyama M, Morrison RS, Black IB, Dreyfus C: Septal neuron cholinergic function: Differential regulation by basic FGF, EGF and TGFα. Brain Res In Press, 1993Google Scholar
  41. 41.
    Wilcox BJ, Unnerstall JR: Expression of acidic fibroblast growth factor mRNA in the developing and adult rat brain. Neuron 6: 397–409, 1991Google Scholar
  42. 42.
    Elde R, Cao Y, Cintra A, Brelje TC, Pelto-Huikko M, Junttila T, Fuxe K, Pettersson RK, Hökfelt T: Prominent expression of acidic fibroblast growth factor in motor and sensory neurons. Neuron 7: 349–364, 1991Google Scholar
  43. 43.
    Schnürch H, Risau W: Differentiating and mature neurons express the acidic fibroblast growth factor gene during chick neural development. Development 111: 1143–1154, 1991Google Scholar
  44. 44.
    Fallon JG, Di Salvo J, Loughlin SE, Gimenez-Gallego G, Seroogy KB, Bradshaw RA, Morrison RS, Ciofi P, Thomas KA: Localization of acidic fibroblast growth factor within the mouse brain using biochemical and immunocytochemical techniques. Growth Factors 6: 139–157, 1992Google Scholar
  45. 45.
    Stock A, Kuzis K, Woodward WR, Nishi R, Eckenstein FP: Localization of acidic fibroblast growth factor in specific subcortical neuronal populations. J Neurosci 12(12): 4688–4700, 1992Google Scholar
  46. 46.
    Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H, Hatanaka M: Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 87: 5710–5714, 1990Google Scholar
  47. 47.
    Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE: Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 50: 7393–7398, 1990Google Scholar
  48. 48.
    Stefanik DF, Rizkalla LR, Soi A, Goldblatt SA, Rizkalla WM: Acidic and basic fibroblast growth factors are present in glioblastoma multiforme. Cancer Res 51: 5760–5765, 1991Google Scholar
  49. 49.
    Morrison RS: Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem. 266: 728–734, 1991Google Scholar
  50. 50.
    Murphy PR, Sato Y, Knee RS: Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Molecular Endocrinology 6: 877–884, 1992Google Scholar
  51. 51.
    Gerdes W, Brysch W, Schlingensiepen K-H, Seifert W: Antisense bFGF oligodeoxynucleotides inhibit DNA synthesis of rat astocytes. Neuro Report 3: 43–46, 1992Google Scholar
  52. 52.
    Takahashi JA, Fukumoto M, Kozai Y, Ito N, Oda Y, Kikuchi H, Hatanaka M: Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor. FEBS Letters 288: 65–71, 1991Google Scholar
  53. 53.
    Morrison RS, Giordano S, Yamaguchi F, Hendrickson S, Berger MS, Palczewski K: Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells. J Neurosci Res 34: 502–509, 1993Google Scholar
  54. 54.
    Sherman L, Stocker KM, Morrison RS, Ciment G: Basic fibroblast growth factor (bFGF) acts intracellularly to cause the transdifferentiation of avian neural crest-derived schwann cell precursors into melanocytes. Development In Press, 1993Google Scholar
  55. 55.
    Morrison RS, Gross JL, Herblin WF, Reilly TM, LaSala PA, Alterman RL, Moskal JR, Kornblith PL, Dexter DL: Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res 50: 2524–2529, 1990Google Scholar
  56. 56.
    Johnson DE, Williams LT: Structural and functional diversity in FGF receptor multigene family. Advance Cancer Res 60: 1–41, 1992Google Scholar
  57. 57.
    Lai C, Lemke G: An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 6: 691–704, 1991Google Scholar
  58. 58.
    Peters KG, Werner S, Chen G, Williams LT: Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114: 233–243, 1992Google Scholar
  59. 59.
    Wanaka A, Johnson EM Jr, Milbrandt J: Localization of FGF receptor mRNA in the adult rat central nervous system byin situ hybridization. Neuron 5: 267–281, 1990Google Scholar
  60. 60.
    Wanaka A, Millbrandt J, Johnson EM Jr:: Expression of FGF receptor gene in rat development. Development 111: 455–468, 1991Google Scholar
  61. 61.
    Heuer JG, Bartheld CS, Kinoshita Y, Evers PC, Bothwell M: Alternative phases of FGF receptor and NGF receptor expression in the developing chicken nervous system. Neuron 5: 283–296, 1990Google Scholar
  62. 62.
    Mattel MG, Moreau A, Gesnel M-C, Houssaint E, Breathnach R: Assignment byin situ hybridization of a fibroblast growth factor receptor gene to human chromosome band 10Q26. Hum Genet 87: 84–86, 1991Google Scholar
  63. 63.
    Rasheed BKA, Fuller GN, Friedman AH, Bigner DD, Bigner SH: Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes & Cancer 5: 75–82, 1992Google Scholar
  64. 64.
    James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546–5551, 1988Google Scholar
  65. 65.
    Rasheed BKA, Bigner SH: Genetic alterations in glioma and medulloblastoma. Cancer & Metastasis Reviews 10: 289–299, 1991Google Scholar
  66. 66.
    Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins F, Weston A, Modali R, Harris CC, Vogelstein B: Mutalions in the p53 gene occur in diverse human tumor types. Nature 342: 705–708, 1989Google Scholar
  67. 67.
    Hayashi Y, Yamashila J, Yamaguchi K: Timing and role of p53 gene mutation in the recurrence of glioma. Biochem Biophys Res Comm 180: 1145–1150, 1991Google Scholar
  68. 68.
    Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelslein B: Clonal expansion of p53 mutanl cells is associated with brain tumor progression. Nature 355: 846–847, 1992Google Scholar
  69. 69.
    Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW, Ullrich SJ: Negative growth regulation in a glioblastoma lumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87: 6166–6170, 1990Google Scholar
  70. 70.
    Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM: Wild-lype p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937–948, 1992Google Scholar
  71. 71.
    Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tisty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.Google Scholar
  72. 72.
    Harvey M, Sands AT, Weiss RS, Wisemann RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A, Donehower LA:In vitro growth characteristics of embryo fibroblasts isolated from p53-deficienl mice. Oncogene, In Press, 1993Google Scholar
  73. 73.
    Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215–221, 1992Google Scholar
  74. 74.
    Yamaguchi F, Saya H, Bruner JM and Morrison RS: Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocylomas. Proc Natl Acad Sci USA. 91: 484–488, 1994Google Scholar

Copyright information

© Kluwer Academic Publishers 1994

Authors and Affiliations

  • Richard S. Morrison
    • 1
    • 2
  • Fumio Yamaguchi
    • 1
  • Hideyuki Saya
    • 2
    • 3
  • Janet M. Bruner
    • 4
  • Alan M. Yahanda
    • 5
  • Lawrence A. Donehower
    • 6
  • Mitchel Berger
    • 7
  1. 1.Department of NeurosurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  2. 2.Department of Tumor BiologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  3. 3.Department of Neuro OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  4. 4.Department of NeuropathologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  5. 5.Department of Surgical OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  6. 6.Division of Molecular VirologyBaylor College of MedicineHoustonUSA
  7. 7.Department of NeurosurgeryUniversity of WashingtonSeattleUSA

Personalised recommendations